drugset

drugset / Trial / NCT00573547

Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease

NCT00573547 ↗

Phase 4 Withdrawn Creighton University

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test whether once-weekly prozac therapy leads to reduction in depression in patients requiring kidney dialysis.

Timeline

Start: 2007-02
Primary completion: 2008-08
Completion: 2008-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fluoxetine	Small molecule	90 mg	—

Indications